Monsanto Company (NYSE:MON) EVP Robert T. Fraley sold 52,410 shares of the firm’s stock in a transaction on Monday, July 10th. The stock was sold at an average price of $117.95, for a total transaction of $6,181,759.50. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Shares of Monsanto Company (NYSE:MON) traded down 0.40% during trading on Tuesday, reaching $117.29. 1,590,279 shares of the company’s stock were exchanged. The firm has a market capitalization of $51.53 billion, a PE ratio of 25.33 and a beta of 1.08. The company’s 50-day moving average price is $117.17 and its 200 day moving average price is $112.81. Monsanto Company has a 52 week low of $97.35 and a 52 week high of $118.97.

Monsanto Company (NYSE:MON) last announced its earnings results on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.74 by $0.19. The firm had revenue of $4.23 billion during the quarter, compared to analyst estimates of $4.18 billion. Monsanto Company had a net margin of 14.11% and a return on equity of 45.26%. Monsanto Company’s revenue was up 1.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.17 EPS. Analysts predict that Monsanto Company will post $4.89 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, July 28th. Investors of record on Friday, July 7th will be given a $0.54 dividend. The ex-dividend date of this dividend is Wednesday, July 5th. This represents a $2.16 dividend on an annualized basis and a yield of 1.84%. Monsanto Company’s dividend payout ratio is presently 46.75%.

TRADEMARK VIOLATION NOTICE: This report was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this report on another domain, it was illegally stolen and republished in violation of US & international trademark and copyright legislation. The correct version of this report can be viewed at https://www.americanbankingnews.com/2017/07/11/robert-t-fraley-sells-52410-shares-of-monsanto-company-nysemon-stock.html.

A number of institutional investors have recently made changes to their positions in MON. Delta Asset Management LLC TN raised its position in Monsanto Company by 0.5% in the first quarter. Delta Asset Management LLC TN now owns 1,950 shares of the basic materials company’s stock valued at $221,000 after buying an additional 10 shares during the period. Savant Capital LLC raised its position in Monsanto Company by 0.4% in the first quarter. Savant Capital LLC now owns 3,082 shares of the basic materials company’s stock valued at $349,000 after buying an additional 11 shares during the period. Guardian Life Insurance Co. of America raised its position in Monsanto Company by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,689 shares of the basic materials company’s stock valued at $191,000 after buying an additional 11 shares during the period. Greenwich Wealth Management LLC raised its position in Monsanto Company by 0.6% in the first quarter. Greenwich Wealth Management LLC now owns 2,565 shares of the basic materials company’s stock valued at $290,000 after buying an additional 15 shares during the period. Finally, Dubuque Bank & Trust Co. raised its position in Monsanto Company by 0.7% in the first quarter. Dubuque Bank & Trust Co. now owns 3,425 shares of the basic materials company’s stock valued at $388,000 after buying an additional 25 shares during the period. Hedge funds and other institutional investors own 74.87% of the company’s stock.

Several analysts have recently weighed in on MON shares. Zacks Investment Research downgraded shares of Monsanto Company from a “buy” rating to a “hold” rating in a report on Tuesday, July 4th. Citigroup Inc. reaffirmed a “neutral” rating and issued a $126.00 target price (up previously from $125.00) on shares of Monsanto Company in a report on Monday. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a $128.00 target price (up previously from $120.00) on shares of Monsanto Company in a report on Thursday, June 29th. Barclays PLC lifted their target price on shares of Monsanto Company from $115.00 to $120.00 and gave the company an “equal weight” rating in a report on Thursday, June 29th. Finally, BidaskClub raised shares of Monsanto Company from a “sell” rating to a “hold” rating in a report on Thursday, June 29th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and ten have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $123.15.

About Monsanto Company

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Insider Buying and Selling by Quarter for Monsanto Company (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.